Gynecologic Oncology Unit, Catholic University of Campobasso, Italy.
Gynecol Oncol. 2010 Dec;119(3):404-10. doi: 10.1016/j.ygyno.2010.08.004.
Preoperative chemoradiation (CT/RT) has been shown to achieve encouraging results in terms of clinical outcome in locally advanced cervical cancer (LACC). The study aims at analyzing the long-term results of this multimodal approach in a single institution series of 184 cases.
Patients underwent whole pelvic irradiation combined with cisplatin and 5-fluorouracil. After evaluation of clinical response, patients were triaged to surgery. Surgical morbidity was classified according to Chassagne grading system. Univariate and multivariate analyses were used to assess the prognostic and predictive role of clinicopathological parameters.
Clinical response was observed in 96.1% of cases. A total of 174 cases were submitted to radical surgery: 124 patients (71.3%) showed complete/microscopic pathological response. In multivariate analysis, clinical response, stage of disease, and histotype predicted response to CT/RT. With a median follow-up of 58 months, recurrence and death of disease were observed in 42 and 40 patients, respectively. The 5-year DFS was 75.5%, while the 5-year OS was 77.4%. Patients with no residual disease showed a significant longer DFS than patients with microscopic (p value = 0.0128), and macroscopic (p value = 0.0001) residual tumor after treatment. In multivariate analysis, residual tumor and stage of disease were the two most relevant prognostic factors for DFS and OS. As far as long-term toxicity is concerned, 8 out of 22 complications were grade 3/4.
Preoperative CT/RT is worth further investigation in LACC patients, providing encouraging survival outcomes and a favourable long-term toxicity profile.
术前放化疗(CT/RT)已被证明在局部晚期宫颈癌(LACC)的临床结果方面取得了令人鼓舞的效果。本研究旨在分析单中心 184 例患者的这种多模式方法的长期结果。
患者接受全骨盆照射联合顺铂和 5-氟尿嘧啶。在评估临床反应后,患者被分为手术组。根据 Chassagne 分级系统对手术并发症进行分类。采用单因素和多因素分析评估临床病理参数的预后和预测作用。
96.1%的病例观察到临床反应。共有 174 例患者接受根治性手术:124 例患者(71.3%)显示完全/镜下病理反应。多因素分析显示,临床反应、疾病分期和组织类型预测 CT/RT 反应。中位随访 58 个月后,42 例和 40 例患者分别出现疾病复发和死亡。5 年无病生存率(DFS)为 75.5%,5 年总生存率(OS)为 77.4%。无残留疾病的患者的 DFS 明显长于治疗后有镜下(p 值=0.0128)和肉眼(p 值=0.0001)残留肿瘤的患者。多因素分析显示,残留肿瘤和疾病分期是 DFS 和 OS 的两个最重要的预后因素。就长期毒性而言,22 种并发症中有 8 种为 3/4 级。
术前 CT/RT 值得进一步研究 LACC 患者,提供令人鼓舞的生存结果和良好的长期毒性特征。